<DOC>
	<DOCNO>NCT00467753</DOCNO>
	<brief_summary>The propose study design assess effectiveness treatment Oxcarbazepine vs. placebo childhood/adolescent autism . This twelve-week study involve twenty subject age five seventeen diagnosis autism .</brief_summary>
	<brief_title>Oxcarbazepine Versus Placebo Childhood Autism</brief_title>
	<detailed_description>The propose study design assess effectiveness treatment Oxcarbazepine vs. placebo childhood/adolescent autism . This twelve-week study involve twenty subject age five seventeen diagnosis autism . Subjects receive psychiatric medical evaluation study psychiatrist see she/he psychiatric medical illness would interfere ability participate study . These evaluation may take hour complete . In addition , subject ask participate psychiatric interview design determine child 's diagnosis current problem area . The subject 's parent also ask fill psychiatric questionnaire . The interview questionnaires may take 4 hour complete .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Subject autism . Subject five seventeen year age Subject hospitalize . Subject diagnose psychopathic disorder mood disorder , include depression bipolar disorder . Subject display selfinjurious behavior . Subject active seizure disorder epilepsy . Subject unstable medical illness . Subject undergone brain injury . Subject history diabetes . Subject history prior treatment oxcarbazepine 600 mg/day 6 week . Subject use study drug within previous 30 day . Subject pregnant female unwilling use acceptable contraception sexually active .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Irritability</keyword>
	<keyword>Functional Ability</keyword>
	<keyword>Aggression</keyword>
	<keyword>Mood Instability</keyword>
</DOC>